Hopital Pitie-Salpetriere
Paris, 75013, France
NCT Number: NCT03694132
The main objective is to determine the origin of somatosensory alteration in patients with ALS and to evaluate its impact on brain activity by coupling different imaging modalities and indirect electrophysiology.
The secondary objective is to evaluate whether the observed functional changes in MEG / EEG and functional MRI correlate with structural lesions revealed with diffusion MRI (anatomo-functional connectivity of the brain).
Looking for future studies?
Notify Me30 year–80 year
All sexes
Interventional
Not applicable
Paris, 75013, France
Somatosensory evoked potentials (SEPs) produced by ulnar nerve electrical stimulation will be collected with combined MEG and EGG.
Functional MRI will be performed during electrical stimulation of ulnar nerve and during mechanical vibration of ADM tendon.
Brain diffusion MRI will be performed. Anatomical MRI will be done for source location. Brain resting state activity will be recorded with MEG/EEG and fMRI.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
conditioning brain activity with peripheral stimulations
diffusion MRI and tractography for evaluating the brain structures
conditioning brain activity with peripheral stimulations
Time frame: 1 hour
Brain parametric maps
Time frame: 15 min
diffusion brain MRI (tractography)
Institut National de la Santé Et de la Recherche Médicale, France
Other Gov
Evaluation and Characterization of Infraclinical Sensory Deficits in Amyotrophic Lateral Sclerosis by Brain Imaging and Electrophysiology
Acronym: SOM_ALS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01925196
Amyotrophic Lateral Sclerosis, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05562960
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases
Taipei, Taiwan
View Trial DetailsNCT04259255
ALS, Amyotrophic Lateral Sclerosis
Phoenix, Arizona, United States
View Trial DetailsNCT05189106
Alzheimer Disease, Amyotrophic Lateral Sclerosis
Boston, Massachusetts, United States
View Trial Details